Cat. No. | Product name | CAS No. |
DC8086 |
Moclobemide
Featured
Moclobemide belongs to a new generation of short-acting, reversible, monoamine oxidase (MAO) inhibitors. |
71320-77-9 |
DC11207 |
INCB13739
Featured
INCB13739 (INCB-13739) is a potent, selective, oral 11βHSD1 inhibitor (IC50=1.1 nM) with high seelctivity over other dehydrogenases, glucocorticoid and mineralocorticoid receptors.. |
872506-67-7 |
DC7818 |
(-)Blebbistatin
Featured
(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly. |
856925-71-8 |
DC22303 |
(-)-Eburnamonine
Featured
(-)-Eburnamonine is a vasodilator that also acts as a cerebral metabolic stimulant. |
4880-88-0 |
DC7961 |
(-)MK-801 maleate
Featured
(-)-MK 801 Maleate is the enantiomer of (+)-MK-801; (+)-MK-801 is a highly potent and selective non-competitive NMDA glutamate receptor antagonist . |
121917-57-5 |
DC10625 |
(+)-Bicuculline
Featured
(+)-Bicuculline is a competitive antagonist of GABAA receptors with IC50 of 2 μM, also blocks Ca(2+)-activated potassium channels. |
485-49-4 |
DC10656 |
(+)-JQ1 carboxylic acid
Featured
(+)-JQ1 carboxylic acid is the carboxylic acid form of (+)-JQ1 for derivative synthesis. |
202592-23-2 |
DC5019 |
(+)-JQ1
Featured
(+)-JQ1 is a BET bromodomain inhibitor, binding to all bromodomains of the BET family, but not to bromodomains outside the BET family. |
1268524-70-4 |
DC12021 |
(+)-JQ1 PA
Featured
(+)-JQ1 PA is a Click-activated (alkyne) version of the BET bromodomain inhibitor (+)-JQ1. |
2115701-93-2 |
DC22282 |
Praeruptorin A
Featured
(+)-Praeruptorin A is a coumarin derivative originally isolated from P. praeruptorum. |
73069-27-9 |
DCAPI1411 |
Bisoprolol Fumarate
Featured
(±)-Bisoprolol hemifumarate is a selective β1-AR adrenergic antagonist. Possesses β1/β2 selectivity of approximately 100-fold and a Kd of 2-3 nM at the β1-AR (β1 receptor). |
104344-23-2 |
DC10094 |
(±)-SLV319(Ibipinabant)
Featured
(±)-SLV 319 is a potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. |
362519-49-1 |
DC22327 |
(20R)-Protopanaxdiol
Featured
(20R)-Protopanaxdiol has protective effect on myocardial ischemia, which may be related to improving free radicals metabolism and myocardial metabolism, decreasing plasma TXA 2 levels. |
7755-01-3 |
DC9833 |
(20S)-Protopanaxadiol
Featured
(20S)-Protopanaxadiol (20-Epiprotopanaxadiol) is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin; apoptosis inducer. |
30636-90-9 |
DC10832 |
(E/Z)-4-hydroxy Tamoxifen
Featured
(E/Z)-4-hydroxy Tamoxifen is an active metabolite of tamoxifen that is formed by the action of cytochrome P450 2D6 in human liver. |
68392-35-8 |
DC23181 |
(R)-GNE-140
Featured
(R)-GNE-140 (GNE-140) is a novel potent, selective lactate dehydrogenase (LDH) inhibitor with IC50 of 3, 5, and 5 nM for LDHA, LDHB, and LDHC, respectively. |
2003234-63-5 |
DC10521 |
(R)-IMPP
Featured
(R)-IMPP is a cell-permeable inhibitor of the secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9; IC50 = 4.8 µM). |
2133832-83-2 |
DC12403 |
(R)-ND-336
Featured
(R)-ND-336 is a potent and selective small-molecule MMP-9 inhibitor with Ki of 19 nM, weakly inhibits MMP-2 and MMP-14 (Ki=127 and 119 nM), poorly inhibits other MMPs (Ki>10 uM). |
2252493-33-5 |
DC20247 |
(R,R)-BNC375
Featured
(R,R)-BNC375 is a potent, selective, and orally available type I positive allosteric modulator of α7 nAChRs. |
|
DC23000 |
(-)-Perillyl alcohol
Featured
(S)-(-)-Perillyl alcohol is a monoterpenoid compound found in the essential oils of cherries, lavender and spearmint. |
536-59-4 |
DC8451 |
(S)-Equol
Featured
(S)-Equol preferentially binds ERβ (Ki = 0.73 nM) and demonstrates approximately 9-fold lower affinity for ERα (Ki = 6.41 nM). |
531-95-3 |
DC9137 |
Timolol Maleate
Featured
(S)-Timolol maleate, is a potent non-selective β-adrenergic receptor antagonist (Ki values are 1.97 and 2.0 nM for β1 and β2 receptor subtypes respectively). |
26921-17-5 |